Skip to main content
. 2022 Dec 16;13:1074911. doi: 10.3389/fendo.2022.1074911

Figure 1.

Figure 1

The regulation of PPARα in MAFLD. Activation of PPARα with agonists including fibrates and Wy14643 influences hepatocytes and immune cells in the liver. In hepatocytes, PPARα agonism promotes lipid transport and oxidation for lipid clearance; moreover, PPARα activation leads to ROS reduction. PPARα agonists inhibit proinflammatory cytokine production of immune cells in the liver, which protects against dysfunction of hepatocytes.